CNCentene Corporation company profile
$71.27+1.42%Close 13 Nov 2026 · Market value $36.93B
About Centene Corporation
Centene Corporation is a managed care company that offers health insurance products to individuals and families across the United States, including Medicaid, Medicare, and Marketplace coverage. Its Medicaid segment, which contributed 57% of total external revenues for 2025, serves low-income families, individuals with disabilities, and children through state-based programs in 30 states. Its Medicare segment includes Medicare Advantage, Dual Eligible Special Needs Plans, and stand-alone prescription drug plans offered in 50 states and the District of Columbia. Its Commercial segment provides Marketplace coverage under the Ambetter Health brand in 29 states and off-exchange individual products. The Other segment includes specialty pharmacy, vision and dental services, clinical healthcare, and behavioral health operations.
A summary of the business section of the company's latest annual report, filed 17 Feb 2026.
Company facts
| Ticker | CNC · NYSE |
|---|
| Sector | Insurance |
|---|
| Industry | Managed Health Care |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 1071739 |
|---|
| Latest annual report | 10-K, filed 17 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Kenneth A. Burdick | Director | 370K · < 1% | Open-market sale, 10 Jun 2026 |
|---|
| Frederick H. Eppinger | Director | 360K · < 1% | Grant or award, 30 Sep 2026 |
|---|
| Sarah M. London | Chief Executive Officer · Director | 335K · < 1% | Shares withheld for tax, 15 Mar 2026 |
|---|
| Andrew L. Asher | Chief Financial Officer | 315K · < 1% | Shares withheld for tax, 15 Mar 2026 |
|---|
| Christopher A. Koster | Secretary & General Counsel | 132K · < 1% | Open-market sale, 26 Aug 2026 |
|---|
| Theodore R. Samuels | Director | 61.8K · < 1% | Grant or award, 30 Sep 2026 |
|---|
| H. James Dallas | Director | 55.6K · < 1% | Grant or award, 12 May 2026 |
|---|
| Christopher J. Coughlin | Director | 53.1K · < 1% | Grant or award, 30 Sep 2026 |
|---|
| Jessica L. Blume | Director | 48.6K · < 1% | Grant or award, 12 May 2026 |
|---|
| Susan Smith | Chief Operating Officer | 32.8K · < 1% | Shares withheld for tax, 15 Jun 2026 |
|---|
| Monte E. Ford | Director | 20.8K · < 1% | Grant or award, 12 May 2026 |
|---|
| Tanya McNally | Chief People Officer | 19.0K · < 1% | Shares withheld for tax, 15 Apr 2026 |
|---|
| Kenneth Y. Tanji | Director | 6.7K · < 1% | Grant or award, 30 Sep 2026 |
|---|
| Tyler Lauren M | Director | — | Grant or award, 30 Sep 2026 |
|---|
| PIENKOS THEODORE J | Corporate Controller & CAO | — | Shares withheld for tax, 15 Sep 2026 |
|---|
| DIAZ PAUL J | Director | — | Grant or award, 28 Jul 2026 |
|---|
| CASSO KATIE | Corporate Controller & CAO | — | Shares withheld for tax, 15 Mar 2026 |
|---|
| DeVeydt Wayne S | Director | — | Grant or award, 30 Jun 2025 |
|---|
| Greco Thomas | Director | — | Grant or award, 13 May 2025 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
CNC in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.